Nebenwirkungen · Bosulif
Bosulif 100 mg film-coated tablets Bosulif 400 mg film-coated tablets Bosulif 500 mg film-coated tablets Bosulif 50 mg hard capsules Bosulif 100 mg hard capsules · Abschnitt 4.8 · PDF-Seite 13–14
HOS-125472 · Präparat HOS-096073
13 Gastrointestinal disorders Very common Diarrhoea Nausea Abdominal paino Vomiting Common Gastritis Gastrointestinal haemorrhagep Pancreatitis acuteq Hepatobiliary disorders Common Hepatic function abnormalr Hepatotoxicitys Uncommon Liver injuryt Skin and subcutaneous tissue disorders Very common Rashu Common Pruritus Acne Urticaria Photosensitivity reactionv Uncommon Drug eruption Exfoliative rash Erythema multiforme Cutaneous vasculitis** Not known Stevens-Johnson Syndrome**, Toxic epidermal necrolysis** Musculoskeletal and connective tissue disorders Very common Arthralgia, Back pain Common Myalgia Renal and urinary disorders Common Acute kidney injury Renal failure Renal impairment General disorders and administration site conditions Very common Fatiguew Pyrexia Oedemax Common Chest painy Pain Investigations Very common Alanine aminotransferase increasedz Aspartate aminotransferase increased Lipase increasedaa Blood creatinine increased Common Amylase increasedbb Blood creatine phosphokinase increased Blood bilirubin increasedcc Gamma-glutamyltransferase increased Electrocardiogram QT prolongeddd a Respiratory tract infection includes Lower respiratory tract infection, Respiratory tract infection, Respiratory tract infection viral, Upper respiratory tract infection, Viral upper respiratory tract infection b Influenza includes H1N1 influenza, Influenza c Pneumonia includes Atypical pneumonia, Pneumonia, Pneumonia bacterial, Pneumonia fungal, Pneumonia necrotising, Pneumonia streptococcal d Thrombocytopenia includes Platelet count decreased, Thrombocytopenia e Anaemia includes Anaemia, Haemoglobin decreased, Red blood cell count decreased f Neutropenia includes Neutropenia, Neutrophil count decreased g Leukopenia includes Leukopenia, White blood cell count decreased
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-01-12T15:15:00Z · SHA-256 86c38605c3386630b4591643bb4507bc13ee17f96b594c991ef48865ec55c6c0 · Passage 57d7cecf308085cc012327e1e26fd906418df98c603ae24e0822b15da6e3493a · Zeichen 3323–5783 im Abschnitt